Early-stage HealthTech Novela Neurotechnologies is a small digital health company with 2-10 employees and revenue in the low-to-mid seven figures range, indicating a high-potential but resource-constrained partner for strategic collaborations, pilots, or channel opportunities in epilepsy care.

Epilepsy Care Focus The firm specializes in continuous, data-driven epilepsy care and has a wearable diary and data platform (Neureka) with a history of research and clinical collaboration, presenting clear cross-selling potential for related neurodiagnostic devices, data analytics services, and remote patient monitoring solutions.

Academic & Clinical Ties Past partnerships with UCSF and a decade-long research legacy position the company for joint research programs, sponsored pilots, and integration opportunities with academic medical centers seeking digital health and neurodata solutions.

Funding & Growth Readiness Revenue estimates of 1–10 million and a track record of product launches and expanding digital health offerings suggest readiness for scaled deployments, pilot programs, and enterprise deals with healthcare providers or payer networks looking to improve epilepsy management outcomes.

Technology & Platform Fit Reliance on common web and frontend technologies plus a focus on data-driven insights implies compatibility with modern cloud-based analytics, remote monitoring ecosystems, and integration with electronic health records, creating opportunities for partnerships with EHR vendors and health IT integrators.